Hello Novavax trial people, hope you don't mind a brief intrusion but I've been on the Valneva trial. Only 150-odd of us so far, which means not many other volunteers to chat to! We're just hitting our "day 106" visits from the first jabs given in late December 2020. Positive results from phase 1/2 were announced this week and they're moving onto phase three in May.
I'm wondering how they will manage a phase three trial under the current circumstances, when even if you try to aim for a student age group of late teenagers, the participants would be entitled to a "proper" licenced vaccine by July. I know you all now have this crossover option so everyone is still blinded but will have an active dose, but you surely need a bit of time with proper unvax'd placebo participants to get the data in. I'm sure the experts will figure something out but been wondering about it!
We're being told it's not advised to mix vaccines, or no science on it yet anyway, so it's not recommended to get a jab from the main rollout when you become eligible. I'm mid thirties so wouldn't get the chance for probably two months yet anyway. So I guess currently like all of you in the crossover stage, I'm vaccinated but unofficially with a dodgy experimental drug!